Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked ...
Jan 9, 2024
0
119
Structural details of an attractive drug target in coronaviruses that could be used against SARS-CoV-2 and in future pandemics have been published today in eLife.
Nov 22, 2022
0
66
Researchers at Northeastern say they've discovered how an antibody could provide broad protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19—even as it evolves ...
Aug 16, 2024
0
29
Last summer, a team of researchers at Université de Montréal succeeded in modeling the spike protein of SARS-CoV-2, the virus responsible for COVID-19, and simulating more than 17,000 possible mutations on a computer.
Jan 20, 2022
0
1
We've now been living with COVID for well over four years. Although there's still much to learn about SARS-CoV-2 (the virus that causes COVID) at least one thing seems clear: it's here to stay.
May 25, 2024
0
53
To combat viruses, one of humankind's oldest threats, researchers are studying predators with the oldest adaptive immune system in the animal kingdom: sharks.
Jun 1, 2022
0
102
A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans—including SARS-CoV-2, the cause of COVID-19—may be possible, say Johns Hopkins Medicine ...
Feb 16, 2022
0
5
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from the Department of Energy's Oak Ridge National Laboratory developed a novel technique.
Jan 26, 2022
0
149
To study a virus as infectious as SARS-CoV-2, researchers need to follow laborious protocols and have access to high-biosafety laboratories. Seeking to make such investigations safer, faster, and accessible to more teams ...
Oct 14, 2021
0
104
Since November 2021, the SARS-CoV-2 Omicron has spread expeditiously all over the world and gradually superseded the previous attention-capturing the SARS-CoV-2 variants of concern (VOCs). The Omicron variant harbors more ...
Apr 22, 2022
0
12
